In early October, Providence Cancer Institute, Pink Lemonade Project (PLP) and the Lobular Breast Cancer Alliance held a free virtual event as part of PLP's Virtually Pink series: Lobular Breast Cancer: Exploring Current Knowledge and Advancing Understanding of This Understudied Disease.
Providence medical breast oncologist Sasha Stanton, M.D., Ph.D. focused on general breast cancer cases and lobular cancer and presented data on the development of a lobular prevention vaccine. Attendees also heard from Laurie Burgess Hutcheson, Executive Director of the LBCA and learned more about how they are raising awareness and supporting patients.
About Sasha Stanton, M.D., Ph.D.
Dr. Stanton is a physician scientist with expertise in breast cancer and extensive training in molecular genetics and immunotherapy. Currently, she leads the Cancer Immunoprevention Laboratory at the Earle A. Chiles Research Institute, a Providence Center of Excellence for immuno-oncology and cellular therapy. She is also a practicing physician at Providence and is board-certified in medical oncology and internal medicine.
Dr. Stanton became interested in breast cancer after witnessing its devastation among friends and family. When she started taking care of patients with cancer, she saw unmet needs that more targeted therapies given earlier in the disease could address. She decided to focus on translational breast cancer research in the emerging field of immuno-oncology.
About Virtually Pink:
Virtually Pink is a program that features topics in an educational format (nutrition, empowerment, medical topics, etc.) to support patients during treatment, recovery, and beyond. It offers an opportunity to build your community of support to live a vibrant life. See more virtual education talks at Virtually Pink Education - Pink Lemonade Project.
Related news
Breast cancer prevention: Separating facts from myths
A new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer
Get to know Dr. Sasha Stanton: Physician, scientist, first soprano
